Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Growth Evaluation, Health Promotion, and Clinical Management in Children and Adolescents With Thalassemia

NCT06931912 is registered in ClinicalTrials.gov with Institute of Hematology & Blood Diseases Hospital, China as lead sponsor.

NCT NCT06931912
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT06931912 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Growth Evaluation, Health Promotion, and Clinical Management in Children and Adolescents With Thalassemia
Lead sponsor
Institute of Hematology & Blood Diseases Hospital, China
Phase
Not applicable
Overall status
Active, not recruiting
Start date
December 1, 2024
Completion date
November 30, 2026
Enrollment
385 (estimated)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

growth delay, puberty, delayed, thalassemia intermedia, thalassemia major